Biotechs emerging from stealth take aim at pharma's prime targets [Yahoo! Finance]

IQVIA Holdings, Inc. (IQV)
Last iqvia holdings, inc. earnings: 4/28 07:00 am
Check Earnings Report
US:NYSE Investor Relations:
ir.iqvia.com
Company Research
Source: Yahoo! Finance
If the recent crop of companies emerging from stealth is any indication, innovators are doubling down on opportunities to join the juggernaut weight loss market while exploring fresh opportunities in immuno-oncology and pain management. Investors appear eager to back their efforts, pouring hundreds of millions into these new initiatives. The flow of capital reflects overall market trends. Global spending on cancer medicine is predicted to increase from $223 billion in 2023 to $409 billion by 2028 , for example. But many of these biotech hopefuls will also face intense competition for market share, particularly in weight loss, where the pipeline contains more than 150 clinical-stage assets, including several in phase 3, according to a recent IQVIA rep
Read more
Impact Snapshot
Event Time:
IQV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IQV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IQV alerts
High impacting IQVIA Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
IQV
News
- Here's Why Investors Must Hold IQV Stock in Their Portfolios Now [Yahoo! Finance]Yahoo! Finance
- Winners And Losers Of Q4: IQVIA (NYSE:IQV) Vs The Rest Of The Drug Development Inputs & Services Stocks [Yahoo! Finance]Yahoo! Finance
- Boasting A 23% Return On Equity, Is IQVIA Holdings Inc. (NYSE:IQV) A Top Quality Stock? [Yahoo! Finance]Yahoo! Finance
- The JurisTrade Litigation Asset Marketplace Recently Launched its Phase 1 Rollout with Over $70 Million in Litigation Funding Opportunities.PR Web
- Achieving Optimal Clinical Trial Performance with Strategic Site Collaboration, Upcoming Webinar Hosted by XtalksPR Web
IQV
Earnings
- 2/6/25 - Beat
IQV
Sec Filings
- 3/10/25 - Form 8-K
- 2/28/25 - Form ARS
- 2/28/25 - Form DEFA14A
- IQV's page on the SEC website